EnBio Holdings Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Yoshikazu Nakamura

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	1.4yrs
Eigendom CEO	5.3%
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	4.9yrs

Recente managementupdates

Recent updates

EnBio Holdings (TSE:6092) Has Affirmed Its Dividend Of ¥8.00

Nov 16

Returns On Capital At EnBio Holdings (TSE:6092) Have Stalled

Aug 07

CEO

Yoshikazu Nakamura (51 yo)

1.4yrs

Tenure

Mr. Yoshikazu Nakamura is Independent Outside Director of User Local, Inc. since September 2024 and was External Auditor. He is Chief Executive Officer, President & Representative Director at EnBio Holding...

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Yoshikazu Nakamura	CEO, President & Representative Director	20.4yrs	geen gegevens	5.32% ¥ 254.9m
Takahiro Hoshino	Independent Outside Director	1.4yrs	geen gegevens	0.12% ¥ 5.9m
Minoru Nishimura	Chairman of the Board	16.8yrs	geen gegevens	6.1% ¥ 292.3m
Tadahide Kameyama	Independent Outside Director	8.4yrs	geen gegevens	0.0012% ¥ 58.9k
Koichiro Hirata	Independent Outside Director	1.4yrs	geen gegevens	2.46% ¥ 118.0m
Ichiro Namekawa	Independent Outside Director	1.4yrs	geen gegevens	0.18% ¥ 8.8m
Toshihito Yamamoto	Director	5.4yrs	geen gegevens	0.19% ¥ 9.1m
Yukinobu Yokomizo	Director	5.4yrs	geen gegevens	0.17% ¥ 8.3m
Yuki Odake	Independent Outside Director	4.4yrs	geen gegevens	0.012% ¥ 590.2k
Kazuo Takayama	Independent Outside Director	1.4yrs	geen gegevens	geen gegevens

4.9yrs

Gemiddelde duur

61.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 6092 wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.9 jaar).

EnBio Holdings Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

EnBio Holdings, Inc, Annual General Meeting, Jun 26, 2024

Less than half of directors are independent

EnBio Holdings, Inc, Annual General Meeting, Jun 24, 2022

Less than half of directors are independent

Recent updates

EnBio Holdings (TSE:6092) Has Affirmed Its Dividend Of ¥8.00

Dividend of JP¥8.00 announced

Now 22% undervalued

EnBio Holdings, Inc to Report Q2, 2025 Results on Nov 14, 2024

Now 20% undervalued

First quarter 2025 earnings released: EPS: JP¥43.14 (vs JP¥22.68 in 1Q 2024)

Returns On Capital At EnBio Holdings (TSE:6092) Have Stalled

Investor sentiment deteriorates as stock falls 18%

EnBio Holdings, Inc (TSE:6092) announces an Equity Buyback for 60,000 shares, representing 0.74% for ¥35 million.

EnBio Holdings, Inc to Report Q1, 2025 Results on Aug 14, 2024

EnBio Holdings, Inc, Annual General Meeting, Jun 26, 2024

Upcoming dividend of JP¥8.00 per share

EnBio Holdings Co., Ltd. to Report Fiscal Year 2024 Results on May 14, 2024

Third quarter 2024 earnings released: EPS: JP¥2.95 (vs JP¥17.46 loss in 3Q 2023)

EnBio Holdings Co., Ltd. to Report Q3, 2024 Results on Feb 14, 2024

EnBio Holdings Co., Ltd. to Report Q2, 2024 Results on Nov 14, 2023

New minor risk - Profit margin trend

First quarter 2024 earnings released: EPS: JP¥22.68 (vs JP¥72.24 in 1Q 2023)

EnBio Holdings, Inc to Report Q1, 2024 Results on Aug 14, 2023

Investor sentiment improves as stock rises 17%

Investor sentiment deteriorates as stock falls 18%

EnBio Holdings, Inc announced that it has received ¥1.056 billion in funding from CRE, Inc.

Upcoming dividend of JP¥8.00 per share at 1.1% yield

Third quarter 2023 earnings released: JP¥17.46 loss per share (vs JP¥30.84 profit in 3Q 2022)

EnBio Holdings, Inc to Report Q3, 2023 Results on Feb 13, 2023

Investor sentiment improved over the past week

Second quarter 2023 earnings released: EPS: JP¥73.37 (vs JP¥20.38 in 2Q 2022)

Less than half of directors are independent

EnBio Holdings, Inc to Report Q2, 2023 Results on Nov 14, 2022

First quarter 2023 earnings released: EPS: JP¥72.24 (vs JP¥36.15 in 1Q 2022)

EnBio Holdings, Inc to Report Q1, 2023 Results on Aug 12, 2022

EnBio Holdings, Inc, Annual General Meeting, Jun 24, 2022

Less than half of directors are independent

EnBio Holdings, Inc to Report Fiscal Year 2022 Results on May 13, 2022

EnBio Holdings, Inc Provides Dividend Guidance for the Year Ending March 31, 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

EnBio Holdings, Inc (TSE:6092) announces an Equity Buyback for 70,000 shares, representing 1.05% for ¥50 million.

EnBio Holdings, Inc to Report Fiscal Year 2021 Results on May 14, 2021

Third quarter 2021 earnings released: EPS JP¥9.73 (vs JP¥6.39 in 3Q 2020)

EnBio Holdings,Inc to Report Q3, 2021 Results on Feb 12, 2021

New 90-day low: JP¥582

EnBio Holdings,Inc to Report Q2, 2021 Results on Nov 13, 2020

EnBio Holdings,Inc to Report Q1, 2021 Results on Aug 12, 2020

CEO

Tenure

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd